Quantcast
Home / IBR Headlines / Novartis paying Idaho $350,000 to settle case

Novartis paying Idaho $350,000 to settle case

A Swiss pharmaceutical company is paying Idaho $350,000 in a settlement of fraud charges. The deal with Novartis, part of a broader case against the Swiss company brought by other states, resolves allegations that it improperly promoted an anti-epileptic drug and engaged in unlawful kickback schemes to get doctors to prescribe medications. Idaho Medicaid will receive $118,661 ...

About The Associated Press